Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative continuation versus withdrawal of ACE inhibitor/ARB therapy
NL-OMON54753Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Sep 2020
- Countries
- 1
01
Overview
Randomised, open-label trial in hypertension (HTN) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Acute kidney injury. Started Sep 2020; status: active, not recruiting.
02
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NL-OMON54753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54753.